Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03140982
Other study ID # Centro Bioetica 2016-05
Secondary ID
Status Completed
Phase N/A
First received April 10, 2017
Last updated May 26, 2017
Start date June 1, 2016
Est. completion date December 15, 2016

Study information

Verified date May 2017
Source Universidad del Desarrollo
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Using very slow or fast propofol intravenous injection, monitored using standard American Society of Anesthesiology (ASA) standard and SEDLine EEG (Med Tech), the patient was evaluate by a neurologist every 30 sec using the FOUR coma scale.


Description:

Clinical experimental randomized study, approved by the Ethic Committee, with informed consent, included ASA I- II adults, without neurological illness and normal physical exam.

The patient randomized in two groups, rapid induction (GR) with propofol in target controlled infusion (TCI) effect site mode using the phamacokinetic (PK) model from Marsh ke0 1,21 min-1 using a calculated target of 5.4 ug/ml (loss of counsciousness EC95) and slow induction (GL) 10 mg/kg/h with calculated effect site concentrations (CeCALC) same PK model.

The same neurologist, blind to the correspondent group, evaluated all the patients every 30 sec using the coma FOUR scale until loss of counsciousness (LOC), defined as a FOUR (E0 no eyes opening response and /or M0 no motor response). At LOC the existance of brainstem reflex was evaluated (B no pupil and corneal reflex), respiratory pattern (R apnoea), CeCALC and patient state index (PSI) SEDline™ was recorded during all the examination.

After LOC in both groups we maintain in GR the initial target (5.3 ug/ml) and the LOC CeCALC during 10 min without intervention, except respiratory support if it was required.

Frontal EEG 4 channel and spectrogram from SEDline monitor was extracted for each case and posterior analysis.

Fisher exact test was used to describe primary outcome and difference between B and R for each group. The difference in time to reach LOC LOC, Ce and PSI was analysed with T- Student.


Recruitment information / eligibility

Status Completed
Enrollment 16
Est. completion date December 15, 2016
Est. primary completion date December 15, 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: ASA 1-2 patients programmed for elective surgery, normal neurologic examination -

Exclusion Criteria: neurologic illness, receiving drugs that affect Central Nervous System during the last 48 hours

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
FOUR coma scale and frontal espectrograpy evaluation
systematic evaluation using the validated FOUR coma scale during propofol administration

Locations

Country Name City State
Chile Clinica Alemana de Santiago Santiago Region Metropolitana

Sponsors (1)

Lead Sponsor Collaborator
Universidad del Desarrollo

Country where clinical trial is conducted

Chile, 

References & Publications (3)

Brown EN, Lydic R, Schiff ND. General anesthesia, sleep, and coma. N Engl J Med. 2010 Dec 30;363(27):2638-50. doi: 10.1056/NEJMra0808281. Review. — View Citation

Mashour GA. Top-down mechanisms of anesthetic-induced unconsciousness. Front Syst Neurosci. 2014 Jun 23;8:115. doi: 10.3389/fnsys.2014.00115. eCollection 2014. Review. — View Citation

Wijdicks EF, Bamlet WR, Maramattom BV, Manno EM, McClelland RL. Validation of a new coma scale: The FOUR score. Ann Neurol. 2005 Oct;58(4):585-93. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary loss of consciousness a cortical or brainsteam phenomenon with fast and slow induction we use the FOUR coma scale ( Ann Neurol. 2005;58(4): 585-93) to identify lost of brain stem activities. 1 year
Secondary evaluation of the alfa band behavior after fast and slow inductions the investigators analyze the time delay in stabilizing the frontal alfa band after fast and slow anesthesia inductions 1 year
See also
  Status Clinical Trial Phase
Completed NCT02012257 - Success Rate of Anterior Middle Superior Alveolar (AMSA) Nerve Block in Three Different Sites of Injection N/A
Not yet recruiting NCT05525351 - The Application and Validation of Triple Drug Response Surface Models on Density Spectral Array in Clinical Anesthesia
Not yet recruiting NCT02937337 - Laryngeal Mask Airway With Video-stylet N/A
Completed NCT01328405 - Air-Q Intubating Laryngeal Airway Versus the Laryngeal Mask Airway (LMA)-Proseal Phase 4
Recruiting NCT03786211 - IANB Success Rate With and Without Panoramic Help Phase 2/Phase 3
Completed NCT03874403 - Anesthetic Component Research on VATS and NIVATS N/A
Recruiting NCT04376307 - Minimal Flow Application in One Lung Ventilation N/A
Completed NCT03533452 - The Impact of a Preoperative Nerve Block on the Consumption of Sevoflurane Phase 2/Phase 3
Completed NCT03386630 - Effects of Analgesics in Cesarean Section Elective Phase 4
Completed NCT05404269 - AGC Mode vs Minimal Flow in Breast Surgery
Recruiting NCT05603442 - Thoracic Intervertebral Foramen Block N/A
Recruiting NCT05754515 - Evaluation of Oxygenation Parameters in Patients Undergoing Rhinoplasty Under General Anesthesia
Completed NCT02455921 - Neuromuscular Blockade Reversal Agent Effect on Postoperative Cognitive Function and Behaviour in Children Phase 4
Completed NCT03480165 - The Efficacy of 20 mg Parecoxib as an Adjunct to 0.75% Ropivacaine in Supraclavicular Brachial Plexus Block for Upper Limb Surgery Phase 3
Completed NCT03486106 - Music Distraction and Its Influence on Anesthetic Requirements During Elective Knee Surgery N/A
Completed NCT03021421 - Comparison of Two Regional Technics In Knee Artroplasty Phase 0
Completed NCT06249113 - Effectiveness of Continous Adjuvant Lidocaine on General Anaesthesia on Tumor Craniotomy Surgery N/A
Completed NCT03438253 - Unwanted Penile Engorgement in Pediatric Patients Under Anesthesia. N/A
Completed NCT03913858 - Low Flow Anesthesia in Morbid Obesity N/A
Completed NCT04813952 - The Effect of Minimal Flow Sevoflurane Anesthesia N/A